MIAMI, USA. February 28th, 2024 - Hello™, a Miami-based innovator in personalized health and wellness, is excited to announce a successful $4 million self-raised pre-seed investment round. This significant financial milestone underscores the company's commitment to revolutionizing the wellness and weight loss industry through its advanced GLP-1 medication therapies and artificial intelligence-driven platform.
With this substantial backing, Hello™ is well-capitalized to embark on its mission to transform the landscape of weight management. The company's unique approach combines the latest in medical science with personalized lifestyle adjustments, offering a bespoke path to wellness that is tailored to the individual needs of each user.
Our mission statement at Hello™ is to redefine what it means to achieve wellness and weight loss. The confidence shown by our investors enables us to accelerate our mission, enhancing our capabilities to deliver personalized, effective, and science-backed weight loss solutions. We're not just creating a product; we're creating a movement towards a healthier future for everyone."
The investment will be utilized to further refine Hello's proprietary technology, expand its team of experts, and increase its outreach to individuals seeking a scientifically grounded and personalized weight loss journey. By focusing on the individuality of each customer's health journey, Hello™ aims to offer more than just weight loss solutions; it aspires to provide a transformative lifestyle change.
In its private opening phase, Hello™ has already demonstrated the effectiveness of its program, with thousands of customers across the United States experiencing significant, sustainable weight loss. With its public launch, the company is set to reach an even wider audience, bringing its revolutionary approach to wellness and weight loss to more individuals nationwide.